Overall survival outcomes in MATTERHORN trial support perioperative durvalumab plus chemotherapy as standard of care.

Adding the CDK4/6 inhibitor abemaciclib to endocrine therapy significantly improves overall survival in node-positive, ...

Saphnelo can now be administered subcutaneously rather than intravenously following the European regulator’s recommendation.

The European Medicines Agency (EMA) has recommended granting marketing authorization in the EU for brensocatib (Brinsupri, ...

The EMA has recommended a first-in-class Bruton’s tyrosine kinase inhibitor to treat immune thrombocytopenia in adults who ...

Patients with presyncope and those with syncope in the ED have similar 30‑day serious cardiac outcomes, although patients ...

Weekly intramuscular injections of rotigotine extended-release microspheres are linked to significant symptom improvement in ...

A large study suggests taking progesterone before pregnancy — not just after conception — may help reduce the risk for ...

General anesthesia leads to better functional outcomes than conscious sedation in stroke patients with large vessel occlusion ...

New draft guidelines on the definition of new active substances don’t apply to deutetrabenazine, the European drug regulator ...

Updates in relapsing-remitting MS from ECTRIMS 2025 examine lifestyle interventions, anti-CD20 therapies, efficacy of ...

Patients with noninfectious intermediate, posterior, or panuveitis requiring immunosuppressive therapy are less likely to ...